Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...
– ABI-5366 is currently being evaluated in ongoing Phase 1b clinical trial with interim proof-of-concept data expected in fall 2025 – SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- ...
The incidence of neonatal herpes simplex virus (HSV) infections in the UK and Ireland increased dramatically over 15 years, and outcomes remained poor, with mortality and long-term neurologic ...
Researchers found that Herpes simplex virus type 1 reorganizes nuclear speckles, essential sites for RNA processing. Without intact speckles, viral messenger RNAs cannot exit the nucleus, limiting ...
Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with ...
The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.
Scientists have hijacked the herpes virus and turned it into a cancer-busting ally. A decade after the United States Food and Drug Administration (FDA) approved the first virus-based cancer therapy, ...
Scientists have uncovered a surprising trick used by the herpes simplex virus to wake up inside the body. Researchers at the University of Virginia School of Medicine have found that a viral protein, ...
(WGN) – Herpes can cause cold sores and fever blisters, and it may also hold the key to understanding cancer. One scientist has spent 30 years studying a virus so ubiquitous that it’s estimated to ...
For many years, scientists have known that the herpes simplex virus-1 (HSV-1), which causes cold sores, can take up residence in parts of neurons in the peripheral nervous system. Stress can even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results